ALKEM LABORATORIES
Back to Balance Sheet
|
ALKEM LABORATORIES Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹15,953 Cr | ₹14,060 Cr | ₹12,454 Cr | ₹12,760 Cr | ₹10,411 Cr |
What is the latest Total Liabilities ratio of ALKEM LABORATORIES ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹15,953 Cr |
| Mar2024 | ₹14,060 Cr |
| Mar2023 | ₹12,454 Cr |
| Mar2022 | ₹12,760 Cr |
| Mar2021 | ₹10,411 Cr |
How is Total Liabilities of ALKEM LABORATORIES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹15,953 Cr | 13.46 | |
| Mar2024 | ₹14,060 Cr | 12.89 | |
| Mar2023 | ₹12,454 Cr | -2.40 | |
| Mar2022 | ₹12,760 Cr | 22.56 | |
| Mar2021 | ₹10,411 Cr | - | |
Compare Total Liabilities of peers of ALKEM LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALKEM LABORATORIES | ₹69,528.3 Cr | 3% | 0.2% | 12.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹409,698.0 Cr | 0.2% | -1.3% | -3.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,866.0 Cr | 1.9% | -6.7% | 0.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹138,062.0 Cr | 1.3% | 2.9% | 28.7% | Stock Analytics | |
| CIPLA | ₹108,412.0 Cr | 1.3% | -8.5% | -7.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,805.0 Cr | 1.3% | 3.8% | 4.5% | Stock Analytics | |
ALKEM LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALKEM LABORATORIES | 3% |
0.2% |
12.5% |
| SENSEX | 0.6% |
0.1% |
9.2% |
You may also like the below Video Courses